PSMA Targeted Molecular Imaging and Radioligand Therapy for Prostate Cancer: Optimal Patient and Treatment Issues

Theranostics (therapy + diagnosis) targeting prostate-specific membrane antigen (PSMA) is an emerging therapeutic modality that could alter treatment strategies for prostate cancer. Although PSMA-targeted radioligand therapy (PSMA-RLT) has a highly therapeutic effect on PSMA-positive tumor tissue, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoshi, Seiji, Yaginuma, Kei, Meguro, Satoru, Onagi, Akifumi, Matsuoka, Kanako, Hata, Junya, Sato, Yuichi, Akaihata, Hidenori, Kataoka, Masao, Ogawa, Soichiro, Uemura, Motohide, Kojima, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453875/
https://www.ncbi.nlm.nih.gov/pubmed/37623010
http://dx.doi.org/10.3390/curroncol30080529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453875/
https://www.ncbi.nlm.nih.gov/pubmed/37623010
http://dx.doi.org/10.3390/curroncol30080529

Ejemplares similares